Blade Air Mobility announces up to $20M share repurchase program; expects FY2024 adj. EBITDA profit

Strata Critical Medical, Inc.

Board authorized repurchase of up to $20M of Class A common stock; program effective through March 31, 2025.
Repurchases to be funded from cash on hand and cash from operations; program may be suspended or discontinued at any time.
Company expects full-year 2024 profitability on an adjusted EBITDA basis, with debt-free balance sheet and significant cash.
Volume and timing of repurchases subject to market conditions, acquisition opportunities, and capital allocation strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.